vs
LAKELAND FINANCIAL CORP（LKFN）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
LAKELAND FINANCIAL CORP的季度营收约是RECURSION PHARMACEUTICALS, INC.的2.0倍（$69.7M vs $35.5M），LAKELAND FINANCIAL CORP净利率更高（38.0% vs -304.2%，领先342.2%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 0.7%）
总部位于美国佛罗里达州坦帕的非银行消费金融服务提供商，由伊恩·麦基奇尼于1989年创立，业务网络仅覆盖佛罗里达州，核心服务涵盖支票兑现、账单支付、预付费卡、发薪日贷款、免费汇票、网点ATM服务、电汇、公证、传真及邮政服务，目前运营近240家线下零售网点。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
LKFN vs RXRX — 直观对比
营收规模更大
LKFN
是对方的2.0倍
$35.5M
净利率更高
LKFN
高出342.2%
-304.2%
两年增速更快
RXRX
近两年复合增速
0.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $69.7M | $35.5M |
| 净利润 | $26.5M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | — | -304.8% |
| 净利率 | 38.0% | -304.2% |
| 营收同比 | — | 681.7% |
| 净利润同比 | 31.8% | 39.6% |
| 每股收益（稀释后） | $1.04 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LKFNRXRX
| Q1 26 | $69.7M | — | ||
| Q4 25 | $69.8M | $35.5M | ||
| Q3 25 | $69.0M | $5.2M | ||
| Q2 25 | $66.4M | $19.2M | ||
| Q1 25 | $63.8M | $14.7M | ||
| Q4 24 | $63.6M | $4.5M | ||
| Q3 24 | $61.2M | $26.1M | ||
| Q2 24 | $68.7M | $14.4M |
净利润LKFNRXRX
| Q1 26 | $26.5M | — | ||
| Q4 25 | $29.9M | $-108.1M | ||
| Q3 25 | $26.4M | $-162.3M | ||
| Q2 25 | $27.0M | $-171.9M | ||
| Q1 25 | $20.1M | $-202.5M | ||
| Q4 24 | $24.2M | $-178.9M | ||
| Q3 24 | $23.3M | $-95.8M | ||
| Q2 24 | $22.5M | $-97.5M |
毛利率LKFNRXRX
| Q1 26 | — | — | ||
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% |
营业利润率LKFNRXRX
| Q1 26 | — | — | ||
| Q4 25 | 52.1% | -304.8% | ||
| Q3 25 | 46.4% | -3327.6% | ||
| Q2 25 | 49.6% | -916.8% | ||
| Q1 25 | 38.0% | -1297.9% | ||
| Q4 24 | 46.0% | -4042.4% | ||
| Q3 24 | 45.3% | -377.1% | ||
| Q2 24 | 39.2% | -697.4% |
净利率LKFNRXRX
| Q1 26 | 38.0% | — | ||
| Q4 25 | 42.8% | -304.2% | ||
| Q3 25 | 38.3% | -3135.3% | ||
| Q2 25 | 40.6% | -894.2% | ||
| Q1 25 | 31.5% | -1373.3% | ||
| Q4 24 | 38.1% | -3935.5% | ||
| Q3 24 | 38.1% | -367.5% | ||
| Q2 24 | 32.8% | -676.6% |
每股收益（稀释后）LKFNRXRX
| Q1 26 | $1.04 | — | ||
| Q4 25 | $1.16 | $-0.17 | ||
| Q3 25 | $1.03 | $-0.36 | ||
| Q2 25 | $1.04 | $-0.41 | ||
| Q1 25 | $0.78 | $-0.50 | ||
| Q4 24 | $0.94 | $-0.56 | ||
| Q3 24 | $0.91 | $-0.34 | ||
| Q2 24 | $0.87 | $-0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $85.6M | $743.3M |
| 总债务越低越好 | $183.6M | $9.6M |
| 股东权益账面价值 | $749.0M | $1.1B |
| 总资产 | $7.1B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.25× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资LKFNRXRX
| Q1 26 | $85.6M | — | ||
| Q4 25 | $141.3M | $743.3M | ||
| Q3 25 | $192.8M | $659.8M | ||
| Q2 25 | $310.2M | $525.1M | ||
| Q1 25 | $235.2M | $500.5M | ||
| Q4 24 | $168.2M | $594.4M | ||
| Q3 24 | $160.2M | $427.6M | ||
| Q2 24 | $121.2M | $474.3M |
总债务LKFNRXRX
| Q1 26 | $183.6M | — | ||
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $30.0M | $20.5M | ||
| Q2 24 | $55.0M | $22.9M |
股东权益LKFNRXRX
| Q1 26 | $749.0M | — | ||
| Q4 25 | $762.4M | $1.1B | ||
| Q3 25 | $747.4M | $1.0B | ||
| Q2 25 | $709.9M | $919.1M | ||
| Q1 25 | $694.4M | $933.9M | ||
| Q4 24 | $683.8M | $1.0B | ||
| Q3 24 | $699.1M | $524.6M | ||
| Q2 24 | $654.5M | $584.4M |
总资产LKFNRXRX
| Q1 26 | $7.1B | — | ||
| Q4 25 | $7.0B | $1.5B | ||
| Q3 25 | $6.9B | $1.4B | ||
| Q2 25 | $7.0B | $1.3B | ||
| Q1 25 | $6.9B | $1.3B | ||
| Q4 24 | $6.7B | $1.4B | ||
| Q3 24 | $6.6B | $726.5M | ||
| Q2 24 | $6.6B | $775.9M |
负债/权益比LKFNRXRX
| Q1 26 | 0.25× | — | ||
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 0.04× | 0.04× | ||
| Q2 24 | 0.08× | 0.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流LKFNRXRX
| Q1 26 | — | — | ||
| Q4 25 | $114.9M | $-46.1M | ||
| Q3 25 | $36.1M | $-117.4M | ||
| Q2 25 | $16.2M | $-76.4M | ||
| Q1 25 | $28.9M | $-132.0M | ||
| Q4 24 | $102.5M | $-115.4M | ||
| Q3 24 | $18.0M | $-59.2M | ||
| Q2 24 | $21.0M | $-82.2M |
自由现金流LKFNRXRX
| Q1 26 | — | — | ||
| Q4 25 | $103.8M | $-47.3M | ||
| Q3 25 | $31.1M | $-117.6M | ||
| Q2 25 | $14.1M | $-79.6M | ||
| Q1 25 | $27.1M | $-133.8M | ||
| Q4 24 | $93.9M | $-116.7M | ||
| Q3 24 | $15.3M | $-63.8M | ||
| Q2 24 | $18.6M | $-83.4M |
自由现金流率LKFNRXRX
| Q1 26 | — | — | ||
| Q4 25 | 148.7% | -133.1% | ||
| Q3 25 | 45.0% | -2272.5% | ||
| Q2 25 | 21.2% | -413.9% | ||
| Q1 25 | 42.5% | -907.4% | ||
| Q4 24 | 147.6% | -2567.7% | ||
| Q3 24 | 25.0% | -244.6% | ||
| Q2 24 | 27.0% | -578.5% |
资本支出强度LKFNRXRX
| Q1 26 | — | — | ||
| Q4 25 | 15.9% | 3.5% | ||
| Q3 25 | 7.3% | 4.7% | ||
| Q2 25 | 3.2% | 16.4% | ||
| Q1 25 | 2.8% | 12.4% | ||
| Q4 24 | 13.6% | 28.6% | ||
| Q3 24 | 4.4% | 17.5% | ||
| Q2 24 | 3.5% | 8.2% |
现金转化率LKFNRXRX
| Q1 26 | — | — | ||
| Q4 25 | 3.84× | — | ||
| Q3 25 | 1.37× | — | ||
| Q2 25 | 0.60× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 4.24× | — | ||
| Q3 24 | 0.77× | — | ||
| Q2 24 | 0.93× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LKFN
| Net Interest Income | $56.8M | 81% |
| Noninterest Income | $12.9M | 19% |
RXRX
暂无分部数据
